Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zgolli Fatma

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Current Drug Safety|November 1, 2024
Facial Hyperpigmentation Following AdalimumabMahjoubi Yasmine Salem, Aouinti Imen, Dahmani Israa, et al.
Current Drug Safety|January 31, 2025
Rhabdomyolysis Following Trimethoprim-Sulfamethoxazole Therapy: A Case Report and Review of the LiteratureMahjoubi Yasmine Salem, Zgolli Fatma, Dahmani Israa, et al.
American Journal of Therapeutics|September 23, 2025
Dobutamine-Associated Superficial ThrombosisInsaf Aoun, Israa Dahmani, Zgolli Fatma, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Current Drug Safety|November 1, 2024
Facial Hyperpigmentation Following AdalimumabMahjoubi Yasmine Salem, Aouinti Imen, Dahmani Israa, et al.
Current Drug Safety|January 31, 2025
Rhabdomyolysis Following Trimethoprim-Sulfamethoxazole Therapy: A Case Report and Review of the LiteratureMahjoubi Yasmine Salem, Zgolli Fatma, Dahmani Israa, et al.
American Journal of Therapeutics|September 23, 2025
Dobutamine-Associated Superficial ThrombosisInsaf Aoun, Israa Dahmani, Zgolli Fatma, et al.
Pageof 1